Saundra S Buys

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. pmc The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer
    Esther M John
    Clinical and Genetic Epidemiology Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA
    Breast Cancer Res 6:R375-89. 2004
  2. ncbi request reprint Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial
    Saundra S Buys
    Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112 5550, USA
    Am J Obstet Gynecol 193:1630-9. 2005
  3. ncbi request reprint Professional opportunities and responsibilities in the provision of genetic information to children relinquished for adoption
    Vickie L Venne
    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA
    Am J Med Genet A 119:41-6. 2003
  4. ncbi request reprint Medical management of skeletal metastasis
    Margaret K Yu
    Division of Medical Oncology, Department of Internal Medicine, University of Utah School of Medicine, 2000 Circle of Hope, Room 3344, Salt Lake City, UT 84112, USA
    Neurosurg Clin N Am 15:529-36, xi. 2004
  5. doi request reprint Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
    Saundra S Buys
    Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, USA
    JAMA 305:2295-303. 2011
  6. pmc Effects of BRCA1 and BRCA2 mutations on female fertility
    Ken R Smith
    Department of Family and Consumer Studies, University of Utah, 225 South 1400 East Alfred Emery Building 228, Salt Lake City, UT 84112, USA
    Proc Biol Sci 279:1389-95. 2012
  7. ncbi request reprint Clinical experience with the NCCN distress thermometer in breast cancer patients
    Michele Dabrowski
    University Hospital Behavioral Health Department, Huntsman Cancer Hospital Patient, Family Support Services, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    J Natl Compr Canc Netw 5:104-11. 2007
  8. pmc The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial
    Christine C Johnson
    Josephine Ford Cancer Center, Henry Ford Hospital, Detroit, MI, USA
    Gynecol Oncol 110:383-9. 2008
  9. ncbi request reprint Ovarian cancer screening in women with a family history of breast or ovarian cancer
    James V Lacey
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA
    Obstet Gynecol 108:1176-84. 2006
  10. pmc A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
    David J Hunter
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Nat Genet 39:870-4. 2007

Detail Information

Publications17

  1. pmc The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer
    Esther M John
    Clinical and Genetic Epidemiology Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA
    Breast Cancer Res 6:R375-89. 2004
    ....
  2. ncbi request reprint Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial
    Saundra S Buys
    Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112 5550, USA
    Am J Obstet Gynecol 193:1630-9. 2005
    ..Ovarian cancer screening with transvaginal ultrasound (TVU) and CA-125 was evaluated in the Prostate, Lung, Colorectal and Ovarian (PLCO) Trial...
  3. ncbi request reprint Professional opportunities and responsibilities in the provision of genetic information to children relinquished for adoption
    Vickie L Venne
    Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA
    Am J Med Genet A 119:41-6. 2003
    ..This article briefly describes the experience and discusses the unique issues that arise in counseling a parent who has relinquished a child who is subsequently at risk to inherit a mutation for an adult onset genetic condition...
  4. ncbi request reprint Medical management of skeletal metastasis
    Margaret K Yu
    Division of Medical Oncology, Department of Internal Medicine, University of Utah School of Medicine, 2000 Circle of Hope, Room 3344, Salt Lake City, UT 84112, USA
    Neurosurg Clin N Am 15:529-36, xi. 2004
    ....
  5. doi request reprint Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
    Saundra S Buys
    Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, USA
    JAMA 305:2295-303. 2011
    ..Screening for ovarian cancer with cancer antigen 125 (CA-125) and transvaginal ultrasound has an unknown effect on mortality...
  6. pmc Effects of BRCA1 and BRCA2 mutations on female fertility
    Ken R Smith
    Department of Family and Consumer Studies, University of Utah, 225 South 1400 East Alfred Emery Building 228, Salt Lake City, UT 84112, USA
    Proc Biol Sci 279:1389-95. 2012
    ..Our findings suggest the need to re-examine the wider role played by BRCA1/2 mutations. Elevated fertility of female mutation carriers indicates that they are more fecund despite their elevated post-reproductive mortality risks...
  7. ncbi request reprint Clinical experience with the NCCN distress thermometer in breast cancer patients
    Michele Dabrowski
    University Hospital Behavioral Health Department, Huntsman Cancer Hospital Patient, Family Support Services, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    J Natl Compr Canc Netw 5:104-11. 2007
    ..In our experience, the tool promoted communication between the patient and the health care team, which enhanced treating psychosocial and physical symptoms. Methods to optimize the use of this screen are proposed...
  8. pmc The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial
    Christine C Johnson
    Josephine Ford Cancer Center, Henry Ford Hospital, Detroit, MI, USA
    Gynecol Oncol 110:383-9. 2008
    ..To determine the epidemiology of CA-125 in women without ovarian cancer...
  9. ncbi request reprint Ovarian cancer screening in women with a family history of breast or ovarian cancer
    James V Lacey
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA
    Obstet Gynecol 108:1176-84. 2006
    ..To evaluate positive predictive values of CA 125 or transvaginal ultrasonography screening for ovarian cancer according to family history of breast or ovarian cancer...
  10. pmc A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
    David J Hunter
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Nat Genet 39:870-4. 2007
    ..Our summary results from the GWAS are available online in a form that should speed the identification of additional risk loci...
  11. ncbi request reprint Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers
    Jeffrey N Weitzel
    Department of Clinical Cancer Genetics, City of Hope Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA
    Clin Cancer Res 13:654-8. 2007
    ..We evaluated the efficacy, safety, and tolerability of hormonal chemoprevention with a gonadotropin-releasing hormone agonist (GnRHA) with low-dose add-back steroids in BRCA1(mut) carriers...
  12. ncbi request reprint BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays
    Anita L Bane
    Department of Pathology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, 600 University Avenue, Toronto, Ontario, Canada
    Am J Surg Pathol 31:121-8. 2007
    ....
  13. ncbi request reprint BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50
    Robert W Haile
    Department of Preventive Medicine, University of Southern California Keck School of Medicine, 1441 Eastlake Avenue, MS 9175, Los Angeles, CA 90089 9175, USA
    Cancer Epidemiol Biomarkers Prev 15:1863-70. 2006
    ..Understanding the effect of oral contraceptives on risk of breast cancer in BRCA1 or BRCA2 mutation carriers is important because oral contraceptive use is a common, modifiable practice...
  14. ncbi request reprint Ovarian volume: determinants and associations with cancer among postmenopausal women
    Mark E Sherman
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Rockville, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 15:1550-4. 2006
    ..Confirmation of these findings in future studies, including analyses of serum hormone levels and tissues, may provide insights into hormonal carcinogenesis among older women...
  15. pmc Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay
    Laurent Perreard
    The ARUP Institute for Clinical and Experimental Pathology, SLC, Utah, USA
    Breast Cancer Res 8:R23. 2006
    ..In the current article, we use microarray analysis and a real-time quantitative reverse-transcription (qRT)-PCR assay to risk-stratify breast cancers based on biological 'intrinsic' subtypes and proliferation...
  16. ncbi request reprint Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Rachael Z Stolzenberg-Solomon
    Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, Suite 320, Rockville, MD 20852, USA
    Am J Clin Nutr 83:895-904. 2006
    ..Several epidemiologic studies suggest that higher folate intakes are associated with lower breast cancer risk, particularly in women with moderate alcohol consumption...
  17. pmc Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium
    Deborah Thompson
    CRC Genetic Epidemiology Unit, Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 4RN, United Kingdom
    Proc Natl Acad Sci U S A 99:827-31. 2002
    ..65 was -11.0]. We conclude that, if a susceptibility gene does exist at this locus, it can only account for a small proportion of non-BRCA1/2 families with multiple cases of early-onset breast cancer...